戻る
TC Biopharm (Holdings) PLC (TCBPY)価格
TCBPY 株価推移チャート
TCBPY 収入
TC Biopharm (Holdings) PLC
$0.07
-28.97%
$-0.02
終値： Jan 20, 16:00:00 GMT-5
$0.12
68.77%
$0.04
アフターマーケット：Jan 20, 20:00:00 GMT-5
主要データ
前終値
$0.1001
始値
$0.1199
当日レンジ
$0.0711 - $0.12
52週レンジ
$0.03 - $9
取引高
220
平均取引高
14.9K
1株当たり利益(TTM)
-7.34
配当利回り
--
時価総額
$1.2M
TCBPYとは何ですか？
TC Biopharm (Holdings) Plc is a clinical-stage biopharmaceutical company, which engages in the development of novel immunotherapy products based on its proprietary allogeneic gamma delta T cell platform. The company employs 39 full-time employees The company went IPO on 2022-02-23. The firm is conducting two investigator-initiated clinical trials for its unmodified GD-T cell product line - phase IIb/III pivotal trial in treatment of AML using its allogeneic CryoTC technology to provide frozen product to clinics worldwide. Its lead product candidate, OmnImmune is an unmodified allogeneic GD-T cell product, being initially used for the treatment of AML. Its pre-clinical stage program is focused on developing CAR-modified allogeneic GD-T cell products targeting solid and hematological indications. The company has an Israeli patent and Japanese patent applications covering the method of preparing and using GD-T cells in the allogeneic treatment of subjects suffering from viral, fungal and protozoal infections or cancer.
